What We Offer
Our Products
Status Flu A+B
Product Overview
Status Flu A+B Rapid Antigen Point-of-Care Test is a lateral flow immunoassay intended for in vitro rapid simultaneous testing for respiratory infections caused by Flu A and Flu B directly from a nasal swab, nasopharyngeal swab, nasal aspirate/wash samples.
  • Flu A+B Rapid POC Antigen Test
  • Simultaneous testing for acute respiratory infections caused by Flu A + B
  • Coverage of 49 Flu strains
  • Lateral flow immunoassay
  • Flu A: PPA 89.2%; NPA 99.4%
  • Flu B: PPA 86.4%; NPA 99.0%
  • Nasal swab, nasopharyngeal swab, nasal aspirate/wash samples
  • Delivers results within 10-15 minutes
  • No equipment necessary
  • CLIA Waived Test
LEARN MORE

Our Products

RCS Healthcare: Our Vision
To be the leading global procurement company for the healthcare community.
LEARN MORE